Insider trades
Sandra Calvin, CAO of Travere Therapeutics TVTX, has filed 0 purchases and 22 sales on the open market. Over the past 12 months that comes to a net sale of $3.9M. The latest trade was on 04/14.
Sandra Calvin
SVP, Chief Accounting Officer
- Company
- Travere Therapeutics TVTX
- First filing
- 23/01/26
- Trades
- 59 trades
- Buys / sales
- 0 / 22
- 12-month net buying
- −$3.9M
- Last trade
- 04/14
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 04/14 | 04/16 | 21,977 sh | $41.07 | $902,595.39 | −34.2% | |
| Open-market sale | 02/03 | 02/03 | 4,333 sh | $32.12 | $139,175.96 | −8.1% | |
| Open-market sale10b5-1 plan | 25/12/24 | 25/12/29 | 7,402 sh | $40.00 | $296,080 | −16.2% | |
| Open-market sale10b5-1 plan | 25/12/15 | 25/12/16 | 2,910 sh | $36.00 | $104,760 | −6.0% | |
| Open-market sale10b5-1 plan | 25/11/04 | 25/11/06 | 67,115 sh | $36.00 | $2,416,140 | −58.0% | |
TVTX | Open-market sale10b5-1 plan | 25/02/11 | 25/02/12 | 54,244 sh5 trades | $25.00avg. | $1,356,100 | −49.9% |
| Open-market sale | 25/02/03 | 25/02/04 | 3,348 sh | $20.12 | $67,361.76 | −5.0% | |
| Open-market sale | 25/01/22 | 25/01/23 | 925 sh | $18.94 | $17,519.5 | −1.7% | |
| Open-market sale10b5-1 plan | 24/12/26 | 24/12/27 | 15,000 sh | $17.22 | $258,300 | −21.5% | |
| Open-market sale | 24/11/25 | 24/11/25 | 12,090 sh | $18.30 | $221,247 | −18.0% | |
| Open-market sale | 24/02/01 | 24/02/02 | 2,820 sh | $8.53 | $24,054.6 | −5.1% | |
| Open-market sale | 24/01/23 | 24/01/25 | 910 sh | $9.07 | $8,253.7 | −2.2% | |
TVTX | Open-market sale10b5-1 plan | 23/05/10–23/05/11 | 23/05/12 | 558 sh2 trades | $16.49avg. | $9,199.88 | −1.3% |
TVTX | Open-market sale | 23/02/01–23/02/02 | 23/02/02 | 2,031 sh2 trades | $21.87avg. | $44,415.45 | −4.5% |
TVTX | Open-market sale | 23/01/24–23/01/25 | 23/01/26 | 1,097 sh2 trades | $21.85avg. | $23,972.46 | −3.1% |